Patents by Inventor Steven Stone

Steven Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160141847
    Abstract: A remote tool device for remotely operating a tool and may include an isolation pole for insulating the remote tool device from the user, a pair of opposing contacts to make an electrical contact in a first position and a second position and a housing to house the contacts. The remote tool device may include a pivoting device to pivot between the first position and the second position.
    Type: Application
    Filed: November 15, 2014
    Publication date: May 19, 2016
    Inventors: Kenny Kenny, Steven Stone
  • Publication number: 20150247208
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: May 15, 2015
    Publication date: September 3, 2015
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Publication number: 20150232947
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: February 26, 2015
    Publication date: August 20, 2015
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Publication number: 20150167103
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia E. Reid
  • Publication number: 20140315935
    Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
    Type: Application
    Filed: February 21, 2014
    Publication date: October 23, 2014
    Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
  • Publication number: 20140170242
    Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
    Type: Application
    Filed: February 19, 2014
    Publication date: June 19, 2014
    Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
  • Publication number: 20130302242
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Application
    Filed: August 30, 2011
    Publication date: November 14, 2013
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Publication number: 20130005592
    Abstract: The invention generally relates to molecular diagnostics, and particularly to molecular markers for cancer therapy response and methods of use thereof.
    Type: Application
    Filed: September 10, 2010
    Publication date: January 3, 2013
    Applicants: Board of Regents of the University of Texas System, Myriad Genetics Incorporated
    Inventors: Steven Stone, Alexander Gutin, Darl Flake, Francisco J. Esteva, Dihua Yu
  • Publication number: 20120053253
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: July 7, 2011
    Publication date: March 1, 2012
    Applicant: Myriad Genetics, Incorporated
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Publication number: 20120041274
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: July 7, 2011
    Publication date: February 16, 2012
    Applicant: Myriad Genetics, Incorporated
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Patent number: 8034564
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: October 11, 2011
    Assignee: University of Utah Research Foundation
    Inventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
  • Publication number: 20110235311
    Abstract: An apparatus and method of protecting a pedestrian or cyclist from accidental collision with a vehicle wherein a first strip is directly or indirectly mounted on the rear of a user; the first strip including a plurality of light emitting devices that emit red light upon activation by a power means; and a second strip that is directly or indirectly mounted on the front of a user; the second strip including a plurality of light emitting devices that emit white, near white light upon activation by a power means; the first and second strips preferably forming an integral part of a garment worn by the user.
    Type: Application
    Filed: March 25, 2010
    Publication date: September 29, 2011
    Applicant: LEDwear Limited
    Inventor: Steven STONE
  • Publication number: 20080085516
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
    Type: Application
    Filed: April 26, 2007
    Publication date: April 10, 2008
    Applicants: Myriad Genetics, Incorporated, University of Utah Research Foundation
    Inventors: Donna Shattuck, Steven Stone, Deanna Russell, Victor Abkevich, Steven Hunt
  • Patent number: 7314713
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: January 1, 2008
    Assignees: Myriad Genetics, Inc., University of Utah
    Inventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
  • Publication number: 20070033707
    Abstract: An improved self adjusting cap for all weather use is disclosed. The improvement lies in the modified attached ear protecting band. The band has an upper edge attached to the crown and a shorter lower edge generally parallel to the upper edge. The lower edge has a shorter linear length than the upper edge so the band more closely conforms to the head of the wearer. Also, the band conforms to the head of the wearer when folded up into the cap without any bunching of material. Additionally, the two forward edges running from the upper edge to the lower edge have an arcuate shape which allows more of the face of the wearer to be protected without obstructing the peripheral vision of the wearer.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 15, 2007
    Inventor: Steven Stone
  • Publication number: 20050203809
    Abstract: The present invention provides a system that facilitates the selection of purchasable items for use in an environs defined by the customer. In one aspect, the system includes a processing element capable of proposing a plurality of purchasable items to the customer for selection by the customer. The processing element also is capable of receiving data representing the environs and data representing at least one purchasable item selected by the customer. The processing element is further capable of generating and displaying a three-dimensional graphical representation of the environs and each purchasable item or items selected by the customer so that the customer can visualize the items in the environs.
    Type: Application
    Filed: March 9, 2004
    Publication date: September 15, 2005
    Inventors: Steven Stone, Santosh Bhasker, Alex Panzano, John Mitchell
  • Patent number: 6210949
    Abstract: The present invention relates to the Multiple Tumor Suppressor (MTS) genes in mice, their expression products, and their homology to the human MTS genes. The human MTS genes are involved in human cancers. The invention is further related to the use of the MTS genes in the therapy, diagnosis and prognosis of human cancer. The invention further relates to mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: April 3, 2001
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Ping Jiang, Alexander Kamb
  • Patent number: 5843756
    Abstract: The present invention relates to the Multiple Tumor Suppressor (MTS) genes in mice, their expression products, and their homology to the human MTS genes. The human MTS genes are involved in human cancers. The invention is further related to the use of the MTS genes in the therapy, diagnosis and prognosis of human cancer. The invention further relates to mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.
    Type: Grant
    Filed: July 28, 1995
    Date of Patent: December 1, 1998
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Ping Jiang, Alexander Kamb
  • Patent number: 5789206
    Abstract: The present invention is directed to cloning the ends of genes. Traditionally it has been very difficult to recover the 5' end of a gene. The present invention greatly eases this problem. The invention is a variation on RACE and uses a combination of techniques. Specific genes are purified by using three enrichment steps--1) a polymerase chain reaction, 2) a hybrid capture step, and 3) a second polymerase chain reaction. The inclusion of the hybrid capture step results in a greater enrichment than occurs with RACE. The ends of the gene are retained by use of a novel technique of attaching adaptors at the ends of the nucleic. The 5' end of the gene is conserved by preparing a first strand of cDNA and ligating to this an adaptor which is partially double stranded wherein the overhang or single stranded region of the adaptor is degenerate which allows for a fraction of the adaptor population to hybridize with the first strand of cDNA at the 3' end of the cDNA.
    Type: Grant
    Filed: July 7, 1995
    Date of Patent: August 4, 1998
    Assignee: Myriad Genetics, Inc.
    Inventors: Sean V. Tavtigian, Steven Stone, Ping Jiang, Alexander Kamb
  • Patent number: 4951413
    Abstract: A troll line depressor includes a pair of triangular wings with a dihedral angle of about 100 degrees therebetween. A rigid bridle connected between the upper and lower ends of the depressor provides a sliding connection for a ring at the end of a towing line, so that the depressor normally develops hydrodynanmic forces to depress the end of the towing line, but can tilt backward to an inoperative position when a fish strikes, or forward to an inoperative position if the depressor engages river bottom debris.
    Type: Grant
    Filed: May 24, 1989
    Date of Patent: August 28, 1990
    Inventors: Bruce D. Blevins, Steven Stone